Uday B. Kompella - Concepedia

Author

Uday B. Kompella

Also Known As

Jack DeRuiter, Kompella, Uday B, Kompella, Uday B., Safa A. Damiati, Samar Damiati, U B Kompella, U. B. Kompella, U.B. Kompella, UDAY B. KOMPELLA, UDAYA BHASKAR KOMPELLA

311

Publications

10.7K

Citations

H-Index

125

Concepts

All Affiliations

University of Nebraska Medical Center University of Colorado Denver University of Colorado Anschutz Medical Campus Nebraska Medical Center University of Montana

About

Uday B. Kompella is an author at University of Nebraska Medical Center specializing in medicine, pharmacology, and ophthalmology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	47	2.7K
2	Engineering	19	23	1.5K
3	Natural Sciences	6	6	533
4	Allergy	4	4	108
5	Health Sciences	3	3	65

Uday B. Kompella

124

Publications

7.8K

Citations

H-Index

Page 1

	Year	Citations
Presenilin 1 Maintains Lysosomal Ca2+ Homeostasis via TRPML1 by Regulating vATPase-Mediated Lysosome Acidification Ju‐Hyun Lee, Mary Kate McBrayer, Devin M. Wolfe, Cell Reports MitophagyVatpase-mediated Lysosome AcidificationMolecular RegulationMolecular BiologyCellular Physiology	2015	347
Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical Applications Henry F. Edelhauser, Cheryl L. Rowe-Rendleman, Michael R. Robinson, Investigative Ophthalmology & Visual Science	2010	254
Subconjunctival Nano- and Microparticles Sustain Retinal Delivery of Budesonide, a Corticosteroid Capable of Inhibiting VEGF Expression Uday B. Kompella, Nagesh Bandi, Surya Ayalasomayajula Investigative Ophthalmology & Visual Science	2003	239
Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration Aniruddha Amrite, Uday B. Kompella Journal of Pharmacy and Pharmacology	2005	207
Hybrid Dendrimer Hydrogel/PLGA Nanoparticle Platform Sustains Drug Delivery for One Week and Antiglaucoma Effects for Four Days Following One-Time Topical Administration Hu Yang, Puneet Tyagi, Rajendra S. Kadam, ACS Nano	2012	204
Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV SanjeetKumar Singh, H. E. Grossniklaus, Seong Jae Kang, Gene Therapy Cell-based Drug DeliveryNanomedicineLaser-induced CnvRgd PeptideEngineering	2009	201
Single Periocular Injection of Celecoxib-PLGA Microparticles Inhibits Diabetes-Induced Elevations in Retinal PGE<sub>2</sub>, VEGF, and Vascular Leakage Aniruddha Amrite, Surya Ayalasomayajula, N. Cheruvu, Investigative Ophthalmology & Visual Science	2006	163
Nano-Advantage in Enhanced Drug Delivery with Biodegradable Nanoparticles: Contribution of Reduced Clearance Rajendra S. Kadam, David W. A. Bourne, Uday B. Kompella Drug Metabolism and Disposition	2012	156
Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model Surya Ayalasomayajula, Uday B. Kompella European Journal of Pharmacology Vascular LeakageOcular DiseaseOphthalmologyMedicineDiabetes	2002	151
Preparation of Drug Delivery Systems Using Supercritical Fluid Technology Kavitha Koushik, Uday B. Kompella Critical Reviews in Therapeutic Drug Carrier Systems NanomedicinePure FractionEngineeringPolymer SeparationSupercritical Fluid Chromatography	2001	139

Page 1